Skip to main content

Infections News (Page 5)

Zemdri (plazomicin) Approved by FDA for the Treatment of Adults with Complicated Urinary Tract Infections (cUTI)

SOUTH SAN FRANCISCO, Calif., June 26, 2018 (GLOBE NEWSWIRE) – Achaogen, Inc., a biopharmaceutical company developing and commercializing innovative antibacterial agents to address multidrug...

FDA Approves Vabomere (meropenem and vaborbactam) for Complicated Urinary Tract Infections

August 29, 2017 – The U.S. Food and Drug Administration today approved Vabomere for adults with complicated urinary tract infections (cUTI), including a type of kidney infection, pyelonephritis,...

FDA Medwatch Alert: Colistimethate for Injection USP, 150 mg and Rifampin for Injection USP, 600 mg/vial by Heritage Pharmaceuticals: Recall - Lack of Sterility Assurance

ISSUE: Heritage Pharmaceuticals Inc. announced the voluntary nationwide recall of ten (10) lots of Colistimethate for Injection, USP, 150 mg Single-Dose vial (NDC 23155-193-31) and three (3) lots of ...

FDA Medwatch Alert: Clinical Specialties Compounding Pharmacy Products: Recall - All Sterile Products Recalled Due To Lack of Sterility Assurance

ISSUE: Clinical Specialties is voluntarily recalling all lots of all sterile products repackaged and distributed by the pharmacy due to lack of sterility assurance. The recall of all sterile products...

Ask a question

To post your own question to our community, sign in or create an account.

Further information

Related condition support groups

Bacterial Infection, Urinary Tract Infection, Sexually Transmitted Diseases, Viral Infection